Full text
PDF


Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Caleffi M., Fentiman I. S., Clark G. M., Wang D. Y., Needham J., Clark K., La Ville A., Lewis B. Effect of tamoxifen on oestrogen binding, lipid and lipoprotein concentrations and blood clotting parameters in premenopausal women with breast pain. J Endocrinol. 1988 Nov;119(2):335–339. doi: 10.1677/joe.0.1190335. [DOI] [PubMed] [Google Scholar]
- Dupont W. D., Page D. L. Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med. 1985 Jan 17;312(3):146–151. doi: 10.1056/NEJM198501173120303. [DOI] [PubMed] [Google Scholar]
- Fentiman I. S., Caleffi M., Brame K., Chaudary M. A., Hayward J. L. Double-blind controlled trial of tamoxifen therapy for mastalgia. Lancet. 1986 Feb 8;1(8476):287–288. doi: 10.1016/s0140-6736(86)90825-1. [DOI] [PubMed] [Google Scholar]
- Fentiman I. S., Caleffi M., Hamed H., Chaudary M. A. Dosage and duration of tamoxifen treatment for mastalgia: a controlled trial. Br J Surg. 1988 Sep;75(9):845–846. doi: 10.1002/bjs.1800750905. [DOI] [PubMed] [Google Scholar]
- Fentiman I. S., Powles T. J. Tamoxifen and benign breast problems. Lancet. 1987 Nov 7;2(8567):1070–1072. doi: 10.1016/s0140-6736(87)91491-7. [DOI] [PubMed] [Google Scholar]
- Fornander T., Rutqvist L. E., Cedermark B., Glas U., Mattsson A., Silfverswärd C., Skoog L., Somell A., Theve T., Wilking N. Adjuvant tamoxifen in early breast cancer: occurrence of new primary cancers. Lancet. 1989 Jan 21;1(8630):117–120. doi: 10.1016/s0140-6736(89)91141-0. [DOI] [PubMed] [Google Scholar]
- Groom G. V., Griffiths K. Effect of the anti-oestrogen tamoxifen on plasma levels of luteinizing hormone, follicle-stimulating hormone, prolactin, oestradiol and progesterone in normal pre-menopausal women. J Endocrinol. 1976 Sep;70(3):421–428. doi: 10.1677/joe.0.0700421. [DOI] [PubMed] [Google Scholar]
- Lynch H. T., Albano W. A., Danes B. S., Layton M. A., Kimberling W. J., Lynch J. F., Cheng S. C., Costello K. A., Mulcahy G. M., Wagner C. A. Genetic predisposition to breast cancer. Cancer. 1984 Feb 1;53(3 Suppl):612–622. doi: 10.1002/1097-0142(19840201)53:3+<612::aid-cncr2820531306>3.0.co;2-5. [DOI] [PubMed] [Google Scholar]
- Miller A. B., Bulbrook R. D. The epidemiology and etiology of breast cancer. N Engl J Med. 1980 Nov 20;303(21):1246–1248. doi: 10.1056/NEJM198011203032130. [DOI] [PubMed] [Google Scholar]
- Moore J. W., Clark G. M., Hoare S. A., Millis R. R., Hayward J. L., Quinlan M. K., Wang D. Y., Bulbrook R. D. Binding of oestradiol to blood proteins and aetiology of breast cancer. Int J Cancer. 1986 Nov 15;38(5):625–630. doi: 10.1002/ijc.2910380502. [DOI] [PubMed] [Google Scholar]
- Pike M. C., Ross R. K., Lobo R. A., Key T. J., Potts M., Henderson B. E. LHRH agonists and the prevention of breast and ovarian cancer. Br J Cancer. 1989 Jul;60(1):142–148. doi: 10.1038/bjc.1989.237. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Powles T. J., Hardy J. R., Ashley S. E., Farrington G. M., Cosgrove D., Davey J. B., Dowsett M., McKinna J. A., Nash A. G., Sinnett H. D. A pilot trial to evaluate the acute toxicity and feasibility of tamoxifen for prevention of breast cancer. Br J Cancer. 1989 Jul;60(1):126–131. doi: 10.1038/bjc.1989.235. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rössner S., Wallgren A. Serum lipoproteins and proteins after breast cancer surgery and effects of tamoxifen. Atherosclerosis. 1984 Sep;52(3):339–346. doi: 10.1016/0021-9150(84)90064-9. [DOI] [PubMed] [Google Scholar]
- Sherman B. M., Chapler F. K., Crickard K., Wycoff D. Endocrine consequences of continuous antiestrogen therapy with tamoxifen in premenopausal women. J Clin Invest. 1979 Aug;64(2):398–404. doi: 10.1172/JCI109475. [DOI] [PMC free article] [PubMed] [Google Scholar]